Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02074891 · ClinicalTrials.gov registry record

Sustainable Healthcenter Implementation PrEP Pilot Study

A clinical trial of HIV Chemoprophylaxis and HIV Preexposure Prophylaxis, sponsored by Centers for Disease Control and Prevention.

Completed
Registry status
1,420
Enrollment target
5
Study locations

NCT02074891 is a study of HIV Chemoprophylaxis and HIV Preexposure Prophylaxis that has completed, run by Centers for Disease Control and Prevention. The registered enrollment target is 1,420 participants. The trial reports 5 study locations across 4 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02074891, a study of HIV Chemoprophylaxis and HIV Preexposure Prophylaxis, has completed, sponsored by Centers for Disease Control and Prevention.

COMPLETED
Registry status
1,420 participants
Enrollment target
5
Study locations

Study Summary

A health services implementation pilot study, conducted with an observational cohort of HIV-uninfected persons including men who have sex with men, heterosexual women and men, and injection drug users receiving daily oral antiretroviral preexposure prophylaxis (PrEP) at four federally qualified health centers that provide sexual health and primary care services to communities with high HIV incidence/prevalence.

Interventions

  • DRUG coformulated TDF/FTC

Study Locations (5)

Illinois

  • Access Community Health Network - Grand Boulevard Health and Specialty Center - Chicago
  • Howard Brown Community Health Center - Chicago

District of Columbia

  • Whitman Walker Health - Washington D.C.

Mississippi

  • Open Arms Healthcare Center - Jackson

Pennsylvania

  • Strawberry Mansion Health Center - Philadelphia

Trial Details

FieldValue
Enrollment Target 1,420 participants
Start Date 2014-10
Est. Completion 2018-11

What the Registry Record Tells You About NCT02074891

The ClinicalTrials.gov registry entry for NCT02074891 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 1,420 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Centers for Disease Control and Prevention, which has 139 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with HIV Chemoprophylaxis appearing as the primary indexed condition, and to 1 intervention - of which coformulated TDF/FTC is the first listed.

NCT02074891 reports 5 study locations spanning 4 distinct geographic areas - top geographies include Illinois, District of Columbia, Mississippi.

Frequently Asked Questions

What is clinical trial NCT02074891 about?

NCT02074891 is a clinical study titled "Sustainable Healthcenter Implementation PrEP Pilot Study". A health services implementation pilot study, conducted with an observational cohort of HIV-uninfected persons including men who have sex with men, heterosexual women and men, and injection drug users receiving daily oral antiretroviral preexposure prophylaxis (PrEP) at four federally qualified heal...

What is the current status of trial NCT02074891?

This trial is currently completed. The enrollment target is 1,420 participants. The study started on 2014-10. Estimated completion is 2018-11.

What conditions does trial NCT02074891 study?

This clinical trial studies the following conditions: HIV Chemoprophylaxis, HIV Preexposure Prophylaxis.

What interventions are being tested in trial NCT02074891?

The interventions under investigation include: coformulated TDF/FTC (DRUG).

Who is sponsoring clinical trial NCT02074891?

This trial is sponsored by Centers for Disease Control and Prevention, which has 139 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02074891 being conducted?

This trial has 5 study locations across District of Columbia, Illinois, Mississippi, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.